CDFF0318

N/A

Report date: 2022/12/15 19:41:38
NME

Base Information

Drug NameCDFF0318
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha-4/beta-2 agonists
TargetsNicotinic acetylcholine receptor alpha-4/beta-2
Therapy Area/IndicationsSmoking Cessation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCtc Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCtcbio Inc
Active IndicationsSmoking Cessation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A